Liver-humanized mice developed as more accurate model of human cardiometabolic diseases Nov. 25, 2021
Discovery of KSQ-004, a Regnase-1/SOCS1 dual-edited human CRISPR/Cas9-engineered TIL therapy Nov. 25, 2021
Animal model recapitulates CCA susceptibility in progressive biliary injury and fibrosis Nov. 24, 2021
A novel protein-engineered IL-12 shows efficacy without peripheral toxicity in animal models Nov. 24, 2021
ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo Nov. 24, 2021